Kronos Bio (KRON) Competitors

CARGO Therapeutics (NASDAQ:CRGX) and Kronos Bio (NASDAQ:KRON) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

Does the media prefer CRGX or KRON?

In the previous week, CARGO Therapeutics had 5 more articles in the media than Kronos Bio. MarketBeat recorded 6 mentions for CARGO Therapeutics and 1 mentions for Kronos Bio. CARGO Therapeutics' average media sentiment score of 0.68 beat Kronos Bio's score of 0.00 indicating that CARGO Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CARGO Therapeutics	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kronos Bio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable earnings & valuation, CRGX or KRON?

Kronos Bio has higher revenue and earnings than CARGO Therapeutics. CARGO Therapeutics is trading at a lower price-to-earnings ratio than Kronos Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CARGO Therapeutics	N/A	N/A	-$167.50M	-$4.62	-1.00
Kronos Bio	$9.85M	5.45	-$86.08M	-$1.07	-0.82

Which has more risk and volatility, CRGX or KRON?

CARGO Therapeutics has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500. Comparatively, Kronos Bio has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500.

Do institutionals & insiders believe in CRGX or KRON?

93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 64.1% of Kronos Bio shares are owned by institutional investors. 2.9% of CARGO Therapeutics shares are owned by insiders. Comparatively, 24.4% of Kronos Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Is CRGX or KRON more profitable?

CARGO Therapeutics has a net margin of 0.00% compared to Kronos Bio's net margin of -701.53%. CARGO Therapeutics' return on equity of -45.93% beat Kronos Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CARGO Therapeutics	N/A	-45.93%	-39.58%
Kronos Bio	-701.53%	-64.22%	-47.17%

Do analysts recommend CRGX or KRON?

CARGO Therapeutics presently has a consensus target price of $15.40, indicating a potential upside of 234.06%. Kronos Bio has a consensus target price of $1.63, indicating a potential upside of 84.66%. Given CARGO Therapeutics' higher possible upside, analysts plainly believe CARGO Therapeutics is more favorable than Kronos Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CARGO Therapeutics	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Kronos Bio	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Kronos Bio beats CARGO Therapeutics on 8 of the 15 factors compared between the two stocks.